CPT code 69716 represents the surgical implantation of a bone‑anchored, magnetically coupled auditory device placed in the mastoid/temporal bone to transmit sound energy to the inner ear through intact skin. This code captures a specific class of implant procedures that remove less than 100 mm² of bone surface and use a transcutaneous magnetic coupling to an external speech processor. Nationally, these implant procedures are significant because they address conductive, mixed, or unilateral sensorineural hearing loss in patients who are candidates for bone‑conduction hearing solutions.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and procedural specifics tied to this code, along with national benchmarking summaries and relevant policy considerations that affect coverage and coding practice. The content outlines typical sites of service, the clinical purpose of the device, and the aspects of the procedure that distinguish 69716 from other otologic implants. Data not available in the input is noted where applicable. The publication is intended to help coding professionals, policy analysts, and clinical administrators quickly understand what this code denotes, which payers commonly cover it, and which topics to consider when aligning clinical documentation and billing for these procedures.